Biobank For MS And Other Demyelinating Diseases

• Register: ClinicalTrials.gov
• Last refreshed on: 11 March 2013
• Main ID: NCT00445367
• Date of registration: 08/03/2007
• Primary sponsor: Accelerated Cure Project for Multiple Sclerosis
• Public title: Biobank For MS And Other Demyelinating Diseases
• Scientific title: Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
• Date of first enrolment: May 2006
• Recruitment status: Enrolling by invitation
• URL: http://clinicaltrials.gov/show/NCT00445367
• Study type: Observational
• Study design: Observational Model: Case Control

Countries of recruitment

United States

Contacts

• Name: Benjamin Greenberg, M.D., M.H.S.
• Affiliation: University of Texas

Key inclusion & exclusion criteria

Inclusion Criteria:

- age 18+ able to give informed consent or individuals younger than 18 with parental
permission and able to give assent

- willing to provide up to 110 ml (50 ml for < 18 years old) of blood via venipuncture

- experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM,
or ON

Exclusion Criteria:

- history of blood borne pathogens

- allogeneic bone marrow transplant

- clinical or radiological evidence of stroke, meningitis, or other well characterized
diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).

- weight less than 37 pounds



Age minimum: N/A
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Acute Disseminated Encephalomyelitis

Multiple Sclerosis

Neuromyelitis Optica

Optic Neuritis

Transverse Myelitis

Secondary ID(s)

ACP-001

Source(s) of Monetary Support

Please refer to primary and secondary sponsors